课题基金 / 基金详情

IDENTIFICATION OF ON AND OFF SIGNALING CASCADE OF MITOTIC CHECKPOINT

IDENTIFICATION OF ON AND OFF SIGNALING CASCADE OF MITOTIC CHECKPOINT
有丝分裂检查点的开关信号级联的识别
批准号:
7957669
负责人:
Don W Cleveland
金额:
$0.33万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2010-08-31

项目摘要

项目成果

Don W Cleveland的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. A cell reproduces by performing an orderly sequence of events in which it duplicates its contents and then divides in two. This cycle of duplication and division is called the cell cycle. At the end of each cycle, called mitotic phase, duplicated chromosomes must be accurately segregated to daughter cells for faithful transmission of genetic information. Errors in this process cause an abnormal number of chromosomes, a hallmark of human tumor progression. In order to assure accurate chromosome segregation, the mitotic checkpoint is activated to arrest cell cycle progression until errors that would generate a lost chromosome have been fixed. Several proteins are known to have pivotal roles in this on and off checkpoint signaling, although the precise mechanisms remains to be further elucidated. I propose here to pursue several approaches to deciphering mitotic checkpoint signal activation, transduction, silencing, and the consequences of deficits from errors in each of these.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
In vivo modelling and therapy development for stathmin-2 loss in TDP-43 proteinopathies
  • 批准号:
    10317404
  • 项目类别:
  • 资助金额:
    $250.73万
  • 财政年份:
    2021
  • 负责人:
    Don W Cleveland
  • 依托单位:
Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD
Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD
Mechanisms of chromosome segregation, aneuploidy, and tumorigenesis
海外基金